Hesaam Esfandyarpour On Raising $240 Million To Create An Ipad Sized Device That Could Help Fight Coronavirus

46:51

Access AI content by logging in

Hesaam Esfandyarpour is the founder and CEO of GenapSys which has developed a novel DNA sequencing technology and detection system for applied genomic testing and medical sequencing. The company has raised $250 million from top tier investors such as Oxford Finance, Foresite Capital, Decheng Capital, and IPV Capital to name a few.